Dr Irani Thevarajan is an infectious disease physician based at the Peter Doherty Institute for Infection and Immunity and is in the clinical and infection prevention pillar of APPRISE. She has an interest in travel medicine, emerging infectious diseases and antimicrobial resistance, and is a member of the antimicrobial stewardship team at The Royal Melbourne Hospital.
Dr Thevarajan is the lead investigator in a prospective observational project in APPRISE that focuses on developing a platform for research preparedness in emerging infections in travellers. In this project, there is collaboration with multiple groups with broad expertise including clinicians and laboratory and public health experts.
- Temporal differences in culturable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) from the respiratory and gastrointestinal tracts in a patient with moderate coronavirus disease 2019 (COVID-19)
- Integrated immune dynamics define correlates of COVID-19 severity and antibody responses
- Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
- Breadth of concomitant immune responses underpinning viral clearance and patient recovery in a non-severe case of COVID-19